Simon Rushbrook
Norfolk and Norwich University Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Pediatric Hepatobiliary Diseases and Treatments, Gallbladder and Bile Duct Disorders, Hepatitis C virus research
Most-Cited Works
- → Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis(2013)393 cited
- → Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease(2016)374 cited
- → British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis(2019)277 cited
- → Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8 + T Cells during Persistent Hepatitis C Virus Infection(2005)274 cited
- → Compromised lymphocytes infiltrate hepatocellular carcinoma(2005)266 cited
- → Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation(2006)255 cited
- → The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis(2019)251 cited
- → Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection(2005)201 cited
- → A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis(2020)188 cited
- → Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group(2022)161 cited